Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21005)

• Formulation Name: Tetrabenazine 12.5 mg tablet
• Company: Lundbeck Pharmaceuticals; Oceanside Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Tetrabenazine	(DMYWQ0O)	Huntington disease	8A01.10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant